B
688073
vs
S
Shanghai Composite
Over the past 12 months, Bide Pharmatech Co Ltd has underperformed Shanghai Composite, delivering a return of +13% compared to the Shanghai Composite's +25% growth.
Stocks Performance
688073 vs Shanghai Composite
Performance Gap
688073 vs Shanghai Composite
Performance By Year
688073 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bide Pharmatech Co Ltd
Glance View
Bide Pharmatech Co., Ltd. engages in research and development of drugs. The company is headquartered in Shanghai, Shanghai and currently employs 617 full-time employees. The company went IPO on 2022-10-11. The firm's main businesses are the research, development, design, production and sales of drug molecular building blocks. The firm's main products are pharmaceutical molecular building blocks and scientific reagents. The firm's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The firm conducts business in Asia Pacific, India, Europe, the United States and other regions.
